Can catheter ablation therapy improve arrhythmia control in patients with drug-refractory atrial fibrillation?
Stephen C Hammill
Correspondence Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Email hammill.stephen@mayo.edu
This article has no abstract so we have provided the first paragraph of the full text.
Haissaguerre and colleagues showed that the majority of AF episodes are initiated by ectopic beats originating from the myocardial sleeve at the pulmonary vein ostia, and that eliminating these foci effectively prevented AF recurrence.1 Catheter-based treatment for AF has evolved rapidly; an anatomical approach is now used to perform circumferential ablation around the pulmonary vein ostia, with or without additional linear lesions to ablate or isolate the pulmonary vein foci.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
